HPR.F - Horizon Pharma Public Limited Company

Frankfurt - Frankfurt Delayed price. Currency in EUR
Show:
Income statement
Balance sheet
Cash flow
Annual
Subscribe to Premium to download historical data

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2019
31/12/2018
31/12/2017
31/12/2016
Total revenue
1,300,029
1,300,029
1,207,570
1,056,231
981,120
Cost of revenue
362,175
362,175
422,317
546,275
393,272
Gross profit
937,854
937,854
785,253
509,956
587,848
Operating expenses
Research development
103,169
103,169
82,762
224,962
60,707
Selling general and administrative
697,111
697,111
692,485
677,363
608,308
Total operating expenses
800,280
800,280
775,247
902,325
669,015
Operating income or loss
137,574
137,574
10,006
-392,369
-81,167
Total other income/expenses net
-70,709
-70,709
-7,460
5,617
-60,308
Income before tax
-20,224
-20,224
-119,146
-513,275
-228,085
Income tax expense
-593,244
-593,244
-44,959
-102,749
-61,251
Income from continuing operations
573,020
573,020
-74,187
-410,526
-166,834
Net income
573,020
573,020
-74,187
-410,526
-166,834
Net income available to common shareholders
573,020
573,020
-74,187
-410,526
-166,834
Basic EPS
-
-
-0.45
-2.52
-1.04
Diluted EPS
-
-
-0.45
-2.52
-1.04
Basic average shares
-
-
166,155
163,123
160,700
Diluted average shares
-
-
166,155
163,123
160,700
EBITDA
-
374,731
285,735
-108,954
140,670
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more